09/11/2025
6:20 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2025
6:24 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2025
6:16 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2025
3:30 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2025
7:00 AM | Clearside Biomedical (Filer)
| Form DEF 14A | |
07/17/2025
6:15 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2025
7:10 AM | Clearside Biomedical (Filer)
| Form ARS | |
04/18/2025
7:00 AM | Clearside Biomedical (Filer)
| Form DEF 14A | |
04/18/2025
7:05 AM | Clearside Biomedical (Filer)
| Form DEFA14A | |
04/08/2025
3:40 PM | Clearside Biomedical (Filer)
| Form PRE 14A | |
04/01/2025
5:09 AM | Clearside Biomedical (Subject)
Wiles Stephen Boyd (Filed by)
| Form SCHEDULE 13G | |
03/27/2025
3:30 PM | Clearside Biomedical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
4:20 PM | Clearside Biomedical (Subject)
WHITMORE BRADFORD T (Filed by)
| Form SCHEDULE 13G/A | |
02/24/2025
4:52 PM | Clearside Biomedical (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:30 PM | Clearside Biomedical (Subject)
Hatteras Venture Advisors IV SBIC, LLC (Filed by)
| Form SCHEDULE 13D/A | |
01/10/2025
3:30 PM | Clearside Biomedical (Issuer)
LASEZKAY GEORGE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
3:30 PM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:15 PM | Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
6:55 AM | Clearside Biomedical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CLSD Stock Alerts